Israel’s MitoCarex Bio has developed its MITOLINE™ algorithm and other advanced computational capabilities to identify small molecules that can fight cancer. MitoCarex has just been acquired by Israel’s N2OFF (see here previously) which is also injecting $1 million of investment.
New way to treat resistant cancers
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.